Frank Burczynski

Dr. Frank Burczynski

orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
GWGuQi Wang
GuQi Wang
HBHerbert L. Bonkovsky
Herbert L. Bonkovsky
ALAndrew de Lemos
Andrew de Lemos
FBFrank Burczynski
Frank Burczynski
Over four decades have passed since liver fatty acid binding protein (FABP)1 was first isolated. There are few protein families for which most of the complete tertiary structures, binding properties, and tissue occurrences are described in such detail and yet new functions are being uncovered for this protein. FABP1 is known to be critical for fatty acid uptake and intracellular transport and also has an important role in regulating lipid metabolism and cellular signaling pathways. FABP1 is an important endogenous cytoprotectant, minimizing hepatocyte oxidative damage and interfering with ischemia-reperfusion and other hepatic injuries. The protein may be targeted for metabolic activation through the cross-talk among many transcriptional factors and their activating ligands. Deficiency or malfunction of FABP1 has been reported in several diseases. FABP1 also influences cell proliferation during liver regeneration and may be considered as a prognostic factor for hepatic surgery. FABP1 binds and modulates the action of many molecules such as fatty acids, heme, and other metalloporphyrins. The ability to bind heme is another cytoprotective property and one that deserves closer investigation. The role of FABP1 in substrate availability and in protection from oxidative stress suggests that FABP1 plays a pivotal role during intracellular bacterial/viral infections by reducing inflammation and the adverse effects of starvation (energy deficiency).

1 April 2007 in Food Research International
Verified
Journal Article
Closed access
PJP. Jiang
P. Jiang
FBFrank Burczynski
Frank Burczynski
CCC. Campbell
C. Campbell
GPGrant Pierce
Grant Pierce
JAJ.A. Austria
J.A. Austria
CBC.J. Briggs
C.J. Briggs

20 September 2005 in Hepatology
Verified
Journal Article
Open access
PDF file
GWGuqi Wang
Guqi Wang
YGYuewen Gong
Yuewen Gong
JAJudy Anderson
Judy Anderson
DSDongfeng Sun
Dongfeng Sun
GMGerald Minuk
Gerald Minuk
FBFrank Burczynski
Frank Burczynski
Liver fatty acid binding protein (L-FABP) contains amino acids that are known to possess antioxidant function. In this study, we tested the hypothesis that L-FABP may serve as an effective endogenous cytoprotectant against oxidative stress. Chang liver cells were selected as the experimental model because of their undetectable L-FABP mRNA level. Full-length L-FABP cDNA was subcloned into the mammalian expression vector pcDNA3.1 (pcDNA-FABP). Chang cells were stably transfected with pc-DNA-FABP or vector (pcDNA3.1) alone. Oxidative stress was induced by incubating cells with 400 μmol/L H2O2 or by subjecting cells to hypoxia/reoxygenation. Total cellular reactive oxygen species (ROS) was determined using the fluorescent probe DCF. Cellular damage induced by hypoxia/reoxygenation was assayed by lactate dehydrogenase (LDH) release. Expression of L-FABP was documented by regular reverse transcription polymerase chain reaction (RT-PCR), real-time RT-PCR, and Western blot. The pcDNA-FABP–transfected cells expressed full-length L-FABP mRNA, which was absent from vector-transfected control cells. Western blot showed expression of 14-kd L-FABP protein in pcDNA-FABP–transfected cells, but not in vector-transfected cells. Transfected cells showed decreased DCF fluorescence intensity under oxidative stress (H2O2 and hypoxia/reoxygenation) conditions versus control in inverse proportion to the level of L-FABP expression. Lower LDH release was observed in the higher L-FABP–expressed cells in hypoxia/reoxygenation experiments. In conclusion , we successfully transfected and cloned a Chang liver cell line that expressed the L-FABP gene. The L-FABP–expressing cell line had a reduced intracellular ROS level versus control. This finding implies that L-FABP has a significant role in oxidative stress. (Hepatology 2005;42:871–879.)

1 April 2000 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
LVLavern M. Vercaigne
Lavern M. Vercaigne
DSDaniel S. Sitar
Daniel S. Sitar
SPS. Brian Penner
S. Brian Penner
KBKeevin Bernstein
Keevin Bernstein
GWGu Qui Wang
Gu Qui Wang
FBFrank Burczynski
Frank Burczynski

30 January 2006 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
JFJianghong Fan
Jianghong Fan
HSHong Shen
Hong Shen
YSYu Sun
Yu Sun
PLPing Li
Ping Li
FBFrank Burczynski
Frank Burczynski
YGYuewen Gong
Yuewen Gong

1 December 2009 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
JYJing Yan
Jing Yan
YGYuewen Gong
Yuewen Gong
Yi-Min SheYi-Min She
Yi-Min She
GWGuqi Wang
Guqi Wang
Michael RobertsMichael Roberts
Michael Roberts
FBFrank Burczynski
Frank Burczynski
Hepatocytes expressing liver fatty acid binding protein (L-FABP) are known to be more resistant to oxidative stress than those devoid of this protein. The mechanism for the observed antioxidant activity is not known. We examined the antioxidant mechanism of a recombinant rat L-FABP in the presence of a hydrophilic (AAPH) or lipophilic (AMVN) free radical generator. Recombinant L-FABP amino acid sequence and its amino acid oxidative products following oxidation were identified by MALDI quadrupole time-of-flight MS after being digested by endoproteinase Glu-C. L-FABP was observed to have better antioxidative activity when free radicals were generated by the hydrophilic generator than by the lipophilic generator. Oxidative modification of L-FABP included up to five methionine oxidative peptide products with a total of ∼80 Da mass shift compared with native L-FABP. Protection against lipid peroxidation of L-FABP after binding with palmitate or α-bromo-palmitate by the AAPH or AMVN free radical generators indicated that ligand binding can partially block antioxidant activity. We conclude that the mechanism of L-FABP's antioxidant activity is through inactivation of the free radicals by L-FABP's methionine and cysteine amino acids. Moreover, exposure of the L-FABP binding site further promotes its antioxidant activity. In this manner, L-FABP serves as a hepatocellular antioxidant.